{
  "docId": "019de075-dfb3-77fc-ad49-0e40af145549",
  "docSlug": "14e0fb6db95d735ce1ade5b4d93a5b22",
  "documentTitle": "Absci | Investor Presentation Deck | 48 slides",
  "authorId": "absci",
  "authorName": "Absci",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 38,
  "pageCount": 48,
  "prevPage": 37,
  "nextPage": 39,
  "slideType": "traction",
  "function": "show_traction",
  "density": "dense",
  "nDataPoints": 5,
  "notes": "The slide uses a bar chart to show relative expression across different nsAA incorporation counts, alongside a structural model of the antibody.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-dfb3-77fc-ad49-0e40af145549/38",
  "deckHref": "/decks/019de075-dfb3-77fc-ad49-0e40af145549",
  "deckJsonHref": "/decks/019de075-dfb3-77fc-ad49-0e40af145549.json",
  "deckAnchorHref": "/decks/019de075-dfb3-77fc-ad49-0e40af145549#slide-38",
  "components": [
    {
      "bbox": {
        "h": 0.15,
        "w": 0.45,
        "x": 0.5,
        "y": 0.75
      },
      "kind": "callout",
      "text": "Bionic SoluPro™ has been able to incorporate a non-standard amino acid into a total of 3 sites of a heavy chain mAB without major reductions in titer",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "de3b0dad-5927-4b05-a6e8-c14b5e30a066",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.45,
        "x": 0.5,
        "y": 0.3
      },
      "kind": "chart",
      "text": "Relative expression of bionic Trastuzumab with varying nsAA sites",
      "attrs": null,
      "subkind": "bar-vertical",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fc021361-9bec-46d9-a4b7-7fdbf11ebdd0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.5,
        "w": 0.35,
        "x": 0.05,
        "y": 0.4
      },
      "kind": "image",
      "text": "Structural model of Trastuzumab with highlighted incorporation sites",
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4cae9d9d-2b26-4069-8110-445493d24568",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.35,
        "x": 0.05,
        "y": 0.3
      },
      "kind": "paragraph",
      "text": "We investigated our ability to produce bionic Trastuzumab with 1, 2, or 3 nsAA incorporation sites",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2fd67936-e158-456a-a44e-f573883942b6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.2,
        "x": 0.05,
        "y": 0.9
      },
      "kind": "source-note",
      "text": "*DAR = Drug-to-Antibody Ratio",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "eb47f17b-cf3a-4c01-a0e5-26a524332c2b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.8,
        "x": 0.05,
        "y": 0.1
      },
      "kind": "title",
      "text": "Increased drug to antibody ratio with the incorporation of multiple nsAAs",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f9530588-56fa-4a73-b1ee-dabfb1ccde67",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Chart Selection Guide",
      "slug": "chart-selection-guide",
      "agent": "Designer",
      "layer": "slide",
      "matchId": "47383360-8550-494f-9575-4f95d6f0da74",
      "evidence": "The slide uses a bar chart to compare the relative expression of bionic Trastuzumab with varying nsAA sites, demonstrating a guide for selecting the right chart type.",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}